Toxno Substance Profile
Evidence-based data. We have more than 25,000 profiles on Toxno.
Use Search below to seek out more. Or browse the Exposure Routes; alternatively see our Lists that have more substances than notes in a Liszt virtuoso piano piece.
Substance Name

Brinzolamide
Identification Number: CASRN | 138890-62-7

  Substance Attributes


  • Has known Side Effects

    This is often the result of long or short term medication use. The same medication can have a range of side effects ranging from none at all to totally debilitating symptoms within different individuals. Reasons for this include individual genetics, individual detoxification capacity, nutrition status, duration of use and total number of medications being taken.


    It becomes very difficult to establish clear causes of symptoms when multiple medications are being taken at once.


    See SIDE EFFECTS LINKOUT at end of this profile.

  • No Nastiness Attributes Yet

    This off course does not mean there aren't any. Toxno just hasn't found any yet. If you know of additional Nastiness Attributes or other Exposure Routes, please let us know. You can contact us , use the comment section on the profile pages or download our data contribution form. Please provide a source or a reference.

These attributes are ONLY based on peer-reviewed evidence. See link to Data Sources below. Everyone benefits from knowing this stuff. Please Share.



  • CATEGORIES: Medication or Drug | Medication Approved in Australian (on the PBS) | Medication Approved in USA | Medication Approved by the European Medicines Agency
  • SUBSTANCE LINEAGE:
  • SYNONYMS:
  • DESCRIPTION: Azopt is indicated to decrease elevated intraocular pressure in: ocular hypertension; open-angle glaucomaas monotherapy in adultpatients unresponsive to beta-blockers or in adultpatients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues.
  • COMMENTS:
  • toxin chemical structure pubchem
  • FORMULA:
  • DATA SOURCES: DATA SOURCES: Drugbank | Australian Approved Medications PBS | USA FDA APPROVED DRUG PRODUCTS | European Medicines Agency
  • LAST UPDATE: 28/04/2018

  Health Associations

Mostly focused on Health Implications of Long Term Exposure to this substance

  • SYMPTOMS:
  • POSSIBLE HEALTH CONSEQUENCES:
  • ACTION OF TOXIN:
  • TOXIN SITES OF ACTION IN CELL:
  • Additional Exposure Routes:
  • SEE MEDICATION SIDE EFFECTS

 Search all of Toxno

Or browse our mind blowing but terrifying Lists.

  Exposure Routes

These are the Exposure Routes we have so far for this substance. There are almost certainly more. We update this section regularly. The number of chemicals with 2 or more nastiness attributes in an exposure route is shown in orange. They grey badge shows the total amount of chemicals within the exposure route.


  Stay Informed

Chemicals released in consumer products and the environment are constantly changing. Regulations change. Exposure Routes change. People speak up and nasties are removed while often others are introduced.

By signing up you will periodically receive updates of potentially life changing information. Both for yourself and your family.

We take security and privacy very seriously and you can unsubscribe at any time.


cats at toxno

"Yeh. We were surprised too"